Literature DB >> 22204320

Functional roles of synaptic and extrasynaptic NMDA receptors in physiological and pathological neuronal activities.

Sheng-Tian Li1, Jue-Gang Ju.   

Abstract

The N-methyl-D-aspartate (NMDA) receptor is a major type of ionotropic glutamate receptor. Many studies have shown that NMDA receptors play a pivotal role in the central nervous system (CNS) under both physiological and pathological conditions. The functional diversity of NMDA receptors can be mainly attributed to their different subunit compositions that perform multiple functions in various situations. Furthermore, recent reports have indicated that synaptic and extrasynaptic NMDA receptors have distinct compositions and couple with different signaling pathways: while synaptic NMDA receptors tend to promote cell survival, extrasynaptic NMDA receptors promote cell death. Currently, intensive efforts are being made to study the pathological role of extrasynaptic NMDA receptors in order to find a more effective approach for the treatment of neurologic disorders. Here we reviewed some recent progress on the participation of synaptic and extrasynaptic NMDA receptors in neurologic diseases including epilepsy, ischemia, schizophrenia, depression and some neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22204320     DOI: 10.2174/138945012799201630

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  10 in total

1.  Microdissection and transcriptional profiling: a window into the pathobiology of preclinical prion disease.

Authors:  Anna Majer; Stephanie A Booth
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

2.  Alzheimer's Disease and Protein Kinases.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Psychoneurochemical investigations to reveal neurobiology of memory deficit in epilepsy.

Authors:  Awanish Mishra; Rajesh Kumar Goel
Journal:  Neurochem Res       Date:  2013-10-08       Impact factor: 3.996

4.  Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice.

Authors:  Anna Majer; Sarah J Medina; Yulian Niu; Bernard Abrenica; Kathy J Manguiat; Kathy L Frost; Clark S Philipson; Debra L Sorensen; Stephanie A Booth
Journal:  PLoS Pathog       Date:  2012-11-08       Impact factor: 6.823

5.  Enhanced expression of NR2B subunits of NMDA receptors in the inherited glaucomatous DBA/2J mouse retina.

Authors:  Ling-Dan Dong; Jie Chen; Fang Li; Feng Gao; Jihong Wu; Yanying Miao; Zhongfeng Wang
Journal:  Neural Plast       Date:  2013-09-22       Impact factor: 3.599

6.  Protective effect of tetrahydroxy stilbene glucoside on learning and memory by regulating synaptic plasticity.

Authors:  Hong-Bo Luo; Yun Li; Zun-Jing Liu; Li Cao; Zhi-Qiang Zhang; Yong Wang; Xiao-Yan Zhang; Zhao Liu; Xiang-Qun Shi
Journal:  Neural Regen Res       Date:  2016-09       Impact factor: 5.135

7.  In silico analysis of binding interaction of conantokins with NMDA receptors for potential therapeutic use in Alzheimer's disease.

Authors:  Maleeha Waqar; Sidra Batool
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-09-20

8.  Anti-epileptic effects of neuropeptide Y gene transfection into the rat brain.

Authors:  Changzheng Dong; Wenqing Zhao; Wenling Li; Peiyuan Lv; Xiufang Dong
Journal:  Neural Regen Res       Date:  2013-05-15       Impact factor: 5.135

9.  GlyCEST: Magnetic Resonance Imaging of Glycine-Distribution in the Normal Murine Brain and Alterations in 5xFAD Mice.

Authors:  Ken Ohno; Masaki Ohkubo; Bingwen Zheng; Masaki Watanabe; Tsuyoshi Matsuda; Ingrid L Kwee; Hironaka Igarashi
Journal:  Contrast Media Mol Imaging       Date:  2021-12-30       Impact factor: 3.161

Review 10.  Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy.

Authors:  Roberta Celli; Francesco Fornai
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.